The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Trigeminal Neuralgia Treatment

Trigeminal neuralgia treatment — management of severe lightning-like facial pain with medication, percutaneous procedures, and surgery.

Treatment of brief but intense facial pain caused by involvement of the fifth cranial (trigeminal) nerve through medical, percutaneous, and surgical options including microvascular decompression and Gamma Knife radiosurgery.

Indication

  • Typical, one-sided, electric-shock or lightning-like sudden facial pain attacks lasting seconds to minutes
  • Pain triggered by talking, chewing, brushing teeth, or cold air
  • Insufficient response to first-line medications such as carbamazepine or oxcarbazepine
  • Cases in which medication cannot be continued because of side effects (loss of balance, low sodium, allergy)
  • Classic trigeminal neuralgia with vascular compression of the trigeminal nerve root on MRI
  • Secondary trigeminal neuralgia due to multiple sclerosis or a tumor

Preparation

  • High-resolution cranial MRI is performed to assess the nerve-vessel relationship
  • Pain intensity, frequency, triggers, and response to previous treatments are documented in detail
  • Blood tests (sodium level, liver enzymes) are monitored while medications are continued
  • If microvascular decompression is planned, full preoperative evaluation for general anesthesia is completed
  • Before Gamma Knife treatment, dental, sinus, and skin assessment is performed and any metal implants are reviewed

How it's performed

  1. First-line therapy is started with carbamazepine or oxcarbazepine; the dose is titrated based on response and side effects
  2. If response is insufficient, additional drugs such as lamotrigine, baclofen, or gabapentin are considered
  3. In drug-resistant cases, percutaneous procedures (radiofrequency rhizotomy, balloon compression, glycerol injection) are options
  4. Microvascular decompression (MVD) is recommended for patients with clear vascular compression on MRI who are fit for general anesthesia; a small cushion is placed between the nerve and the vessel
  5. For patients unsuitable for surgery or with recurrence, Gamma Knife stereotactic radiosurgery delivers a focused beam to the nerve root
  6. Treatment selection is individualized based on age, comorbidities, pain intensity, MRI findings, and patient preference

Post-procedure

  • On medical therapy, the dose, side effects, and sodium levels are reviewed every 4-6 weeks
  • After MVD, 1-2 days of intensive care monitoring and a 4-6 day hospital stay
  • Pain reduction after Gamma Knife develops over weeks to months; control visits at 3 and 12 months
  • When pain recurs, dose adjustment, additional medication, or alternative procedural options are reassessed
  • Facial numbness, corneal sensitivity, or chewing difficulty as side effects are followed closely

Risks

  • Medication side effects: drowsiness, balance disturbance, low sodium (hyponatremia), elevated liver enzymes, serious skin reactions
  • Microvascular decompression: hearing loss, facial numbness or weakness, CSF leak, infection, rare brainstem injury
  • Gamma Knife: delayed facial numbness or dysesthesia (uncomfortable sensation)
  • Percutaneous procedures: corneal sensory loss, chewing muscle weakness, pain recurrence
  • Possibility of pain returning over time with all techniques

FAQ

Is surgery the first treatment for trigeminal neuralgia?

No. First-line treatment is medication such as carbamazepine or oxcarbazepine. If response is inadequate or side effects prevent continuation, procedural and surgical options are considered.

What is the difference between microvascular decompression (MVD) and Gamma Knife?

MVD physically removes vascular compression on the nerve root and provides the highest long-term pain-free rates in classic trigeminal neuralgia, but it requires general anesthesia and open surgery. Gamma Knife is radiation-based and does not require anesthesia, but its effect develops over weeks to months and the risk of numbness may be higher.

Is trigeminal neuralgia a sign of multiple sclerosis?

Trigeminal neuralgia occurs alone in most patients, but in younger patients or in cases with bilateral or atypical features, MRI evaluation for multiple sclerosis is recommended.

Can the pain come back after treatment?

Recurrence is possible with every technique to varying degrees. If pain returns, medications, additional drugs, or alternative procedural options are reviewed again.